Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Cancer Cell. 2012 Aug 14;22(2):139-40. doi: 10.1016/j.ccr.2012.07.012.

Genomic analysis drives tailored therapy in poor risk childhood leukemia.

Author information

  • 1Northern Institute for Cancer Research, Newcastle University, Newcastle upon Tyne, UK. christine.harrison@newcastle.ac.uk

Abstract

Ph-like acute lymphoblastic leukemia (ALL) is a novel subgroup of high-risk childhood ALL. In this issue of Cancer Cell, Roberts et al. describe the identification of genetic alterations that lead to activated kinase and cytokine receptor signaling in Ph-like ALL and demonstrate that this aberrant signaling can be inhibited effectively.

Copyright © 2012 Elsevier Inc. All rights reserved.

Comment on

PMID:
22897843
[PubMed - indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk